pre-IPO PHARMA

COMPANY OVERVIEW

AZTherapies is an advanced clinical stage drug development company innovating the discovery, development and commercialization of novel Alzheimer's Disease and ischemic stroke treatments which could fundamentally improve patient treatment, quality of life and disease management.


LOCATION

  • Boston, MA, USA

  • THERAPEUTIC AREAS


    WEBSITE

    https://aztherapies.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Nov 18, 2020

    AZTherapies Completes COGNITE Phase 3 Alzheimer’s Clinical Trial; Top-Line Data Readout Expected in First Quarter of 2021


    Aug 11, 2020

    AZTherapies Announces the Appointment of Drs. Robert Malenka, Adam Boxer, Vijay Kuchroo and Megan Levings, to Scientific Advisory Board


    Jul 22, 2020

    AZTherapies Strengthens Board of Directors and Business Advisory Board with New Appointments


    Nov 6, 2019

    AZTherapies Announces Appointment of Ernest D. Penachio as Vice President of Manufacturing Operations and CMC


    Oct 24, 2019

    AZTherapies Strengthens Neuroinflammation-Targeted Pipeline Through Acquisition of Smith Therapeutics


    For More Press Releases


    Google Analytics Alternative